Loading…

Possible involvement of PI3K/AKT/mTOR signaling pathway in the protective effect of selegiline (deprenyl) against memory impairment following ischemia reperfusion in rat

Short-term cerebral ischemia led to memory dysfunction. There is a pressing need to introduce effective agents to reduce complications of the ischemia. Involvement of PI3K/AKT/mTOR signaling pathway has been determined in the neuroprotective effect of various agents. Selegiline (deprenyl) possessed...

Full description

Saved in:
Bibliographic Details
Published in:Neuropeptides (Edinburgh) 2019-10, Vol.77, p.101942-101942, Article 101942
Main Authors: Amini-Khoei, Hossein, Saghaei, Elham, Mobini, Gholam-Reza, Sabzevary-Ghahfarokhi, Milad, Ahmadi, Reza, Bagheri, Nader, Mokhtari, Tahmineh
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c450t-c34da2d2fa0747045dd3ce0a882ca39e6eb564e641fc93ea780239d04c157b4a3
cites cdi_FETCH-LOGICAL-c450t-c34da2d2fa0747045dd3ce0a882ca39e6eb564e641fc93ea780239d04c157b4a3
container_end_page 101942
container_issue
container_start_page 101942
container_title Neuropeptides (Edinburgh)
container_volume 77
creator Amini-Khoei, Hossein
Saghaei, Elham
Mobini, Gholam-Reza
Sabzevary-Ghahfarokhi, Milad
Ahmadi, Reza
Bagheri, Nader
Mokhtari, Tahmineh
description Short-term cerebral ischemia led to memory dysfunction. There is a pressing need to introduce effective agents to reduce complications of the ischemia. Involvement of PI3K/AKT/mTOR signaling pathway has been determined in the neuroprotective effect of various agents. Selegiline (deprenyl) possessed neuroprotective properties. In this study global ischemia/reperfusion was established in rats. Selegiline (5 mg/kg for 7 consecutive days) administrated via intraperitoneal route. Possible involvement of PI3K/AKT/mTOR signaling pathway was evaluated using qRT-PCR, immunohistochemistry and histophatologic evaluations in the hippocampus. Spatial memory was evaluated by morris water maze (MWM). Results showed that ischemia impaired the memory and ischemic rats spent more time to find hidden platform in the MWM. Ischemia significantly decreased levels of PI3K, AKT and mTOR in the hippocampus. Histopathologic assessment revealed that the percent of dark neurons significantly increased in the CA1 area of the hippocampus of ischemic rats. Selegiline improved the memory as ischemic rats spent fewer time to find hidden platform in the MWM. Findings showed that selegiline increased the level and expression of PI3K, AKT and mTOR as well as decreased the proportion of dark neurons in the CA1 area of the pyramidal layer of the hippocampus. We concluded that selegiline, partially at least, through increases the expression of PI3K, AKT and mTOR as well as decreases the percent of dark neurons in the hippocampus could improve the memory impairment following the ischemia in rats. •Ischemia led to memory dysfunction in rats.•Ischemia reduced the level of AKT, PI3K, mTOR and p-mTOR.•Ischemia increased the percent of dark (dead) neurons in the hippocampus.•Selegiline reversed the negative effect of ischemia on the memory function.•Selegiline increased the level of AKT, PI3K, mTOR and p-mTOR and decreased the number of dark neurons.
doi_str_mv 10.1016/j.npep.2019.101942
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2253285977</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0143417919300538</els_id><sourcerecordid>2303718197</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-c34da2d2fa0747045dd3ce0a882ca39e6eb564e641fc93ea780239d04c157b4a3</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhS0EotPCC7BAlti0i8z4L3EisakqfqpWaoWGteVxbmY8cuxgJ1PNI_GWOExhwYKVLes7516fg9A7SpaU0Gq1X_oBhiUjtJkfGsFeoAUtOSuYrMuXaEGo4IWgsjlD5yntCSGC1fVrdMYpk6yqxQL9fAwp2Y0DbP0huAP04EccOvx4y-9W13frVb9--IaT3XrtrN_iQY-7J33MOB53gIcYRjCjPQCGrsu3WZvAwdZmHPBlC0MEf3RXWG-19WnEPfQhZoN-0Db-HtcF58LT7G6T2UFvNY4wQOymZIOfR0U9vkGvOu0SvH0-L9D3z5_WN1-L-4cvtzfX94URJRkLw0WrWcs6TaSQRJRtyw0QXdfMaN5ABZuyElAJ2pmGg5Y1YbxpiTC0lBuh-QW6PPnmr_2YII2qz1uBc9pDmJJiLCdcl42UGf3wD7oPU8xBZYoTLmlNm5liJ8rEnHWETg3R9joeFSVqLlLt1VykmotUpyKz6P2z9bTpof0r-dNcBj6eAMhZHCxElYwFb6C1Mdeg2mD_5_8LwTqxiw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2303718197</pqid></control><display><type>article</type><title>Possible involvement of PI3K/AKT/mTOR signaling pathway in the protective effect of selegiline (deprenyl) against memory impairment following ischemia reperfusion in rat</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Amini-Khoei, Hossein ; Saghaei, Elham ; Mobini, Gholam-Reza ; Sabzevary-Ghahfarokhi, Milad ; Ahmadi, Reza ; Bagheri, Nader ; Mokhtari, Tahmineh</creator><creatorcontrib>Amini-Khoei, Hossein ; Saghaei, Elham ; Mobini, Gholam-Reza ; Sabzevary-Ghahfarokhi, Milad ; Ahmadi, Reza ; Bagheri, Nader ; Mokhtari, Tahmineh</creatorcontrib><description>Short-term cerebral ischemia led to memory dysfunction. There is a pressing need to introduce effective agents to reduce complications of the ischemia. Involvement of PI3K/AKT/mTOR signaling pathway has been determined in the neuroprotective effect of various agents. Selegiline (deprenyl) possessed neuroprotective properties. In this study global ischemia/reperfusion was established in rats. Selegiline (5 mg/kg for 7 consecutive days) administrated via intraperitoneal route. Possible involvement of PI3K/AKT/mTOR signaling pathway was evaluated using qRT-PCR, immunohistochemistry and histophatologic evaluations in the hippocampus. Spatial memory was evaluated by morris water maze (MWM). Results showed that ischemia impaired the memory and ischemic rats spent more time to find hidden platform in the MWM. Ischemia significantly decreased levels of PI3K, AKT and mTOR in the hippocampus. Histopathologic assessment revealed that the percent of dark neurons significantly increased in the CA1 area of the hippocampus of ischemic rats. Selegiline improved the memory as ischemic rats spent fewer time to find hidden platform in the MWM. Findings showed that selegiline increased the level and expression of PI3K, AKT and mTOR as well as decreased the proportion of dark neurons in the CA1 area of the pyramidal layer of the hippocampus. We concluded that selegiline, partially at least, through increases the expression of PI3K, AKT and mTOR as well as decreases the percent of dark neurons in the hippocampus could improve the memory impairment following the ischemia in rats. •Ischemia led to memory dysfunction in rats.•Ischemia reduced the level of AKT, PI3K, mTOR and p-mTOR.•Ischemia increased the percent of dark (dead) neurons in the hippocampus.•Selegiline reversed the negative effect of ischemia on the memory function.•Selegiline increased the level of AKT, PI3K, mTOR and p-mTOR and decreased the number of dark neurons.</description><identifier>ISSN: 0143-4179</identifier><identifier>EISSN: 1532-2785</identifier><identifier>DOI: 10.1016/j.npep.2019.101942</identifier><identifier>PMID: 31272684</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>1-Phosphatidylinositol 3-kinase ; AKT protein ; Animal behavior ; Animals ; Brain Ischemia - complications ; Brain Ischemia - metabolism ; Hippocampus ; Hippocampus - drug effects ; Hippocampus - metabolism ; Immunohistochemistry ; Ischemia ; Male ; Maze Learning - drug effects ; Memory ; Memory - drug effects ; Memory Disorders - drug therapy ; Memory Disorders - etiology ; Memory Disorders - metabolism ; Neurons ; Neurons - drug effects ; Neurons - metabolism ; Neuroprotection ; Neuroprotective Agents - pharmacology ; Neuroprotective Agents - therapeutic use ; Phosphatidylinositol 3-Kinases - metabolism ; PI3K/AKT/mTOR signaling ; Proto-Oncogene Proteins c-akt - metabolism ; Rat ; Rats ; Rats, Sprague-Dawley ; Reperfusion ; Rodents ; Selegiline ; Selegiline - pharmacology ; Selegiline - therapeutic use ; Signal transduction ; Signal Transduction - drug effects ; Spatial memory ; TOR protein ; TOR Serine-Threonine Kinases - metabolism</subject><ispartof>Neuropeptides (Edinburgh), 2019-10, Vol.77, p.101942-101942, Article 101942</ispartof><rights>2019</rights><rights>Copyright © 2019. Published by Elsevier Ltd.</rights><rights>Copyright Elsevier Science Ltd. Oct 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-c34da2d2fa0747045dd3ce0a882ca39e6eb564e641fc93ea780239d04c157b4a3</citedby><cites>FETCH-LOGICAL-c450t-c34da2d2fa0747045dd3ce0a882ca39e6eb564e641fc93ea780239d04c157b4a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31272684$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Amini-Khoei, Hossein</creatorcontrib><creatorcontrib>Saghaei, Elham</creatorcontrib><creatorcontrib>Mobini, Gholam-Reza</creatorcontrib><creatorcontrib>Sabzevary-Ghahfarokhi, Milad</creatorcontrib><creatorcontrib>Ahmadi, Reza</creatorcontrib><creatorcontrib>Bagheri, Nader</creatorcontrib><creatorcontrib>Mokhtari, Tahmineh</creatorcontrib><title>Possible involvement of PI3K/AKT/mTOR signaling pathway in the protective effect of selegiline (deprenyl) against memory impairment following ischemia reperfusion in rat</title><title>Neuropeptides (Edinburgh)</title><addtitle>Neuropeptides</addtitle><description>Short-term cerebral ischemia led to memory dysfunction. There is a pressing need to introduce effective agents to reduce complications of the ischemia. Involvement of PI3K/AKT/mTOR signaling pathway has been determined in the neuroprotective effect of various agents. Selegiline (deprenyl) possessed neuroprotective properties. In this study global ischemia/reperfusion was established in rats. Selegiline (5 mg/kg for 7 consecutive days) administrated via intraperitoneal route. Possible involvement of PI3K/AKT/mTOR signaling pathway was evaluated using qRT-PCR, immunohistochemistry and histophatologic evaluations in the hippocampus. Spatial memory was evaluated by morris water maze (MWM). Results showed that ischemia impaired the memory and ischemic rats spent more time to find hidden platform in the MWM. Ischemia significantly decreased levels of PI3K, AKT and mTOR in the hippocampus. Histopathologic assessment revealed that the percent of dark neurons significantly increased in the CA1 area of the hippocampus of ischemic rats. Selegiline improved the memory as ischemic rats spent fewer time to find hidden platform in the MWM. Findings showed that selegiline increased the level and expression of PI3K, AKT and mTOR as well as decreased the proportion of dark neurons in the CA1 area of the pyramidal layer of the hippocampus. We concluded that selegiline, partially at least, through increases the expression of PI3K, AKT and mTOR as well as decreases the percent of dark neurons in the hippocampus could improve the memory impairment following the ischemia in rats. •Ischemia led to memory dysfunction in rats.•Ischemia reduced the level of AKT, PI3K, mTOR and p-mTOR.•Ischemia increased the percent of dark (dead) neurons in the hippocampus.•Selegiline reversed the negative effect of ischemia on the memory function.•Selegiline increased the level of AKT, PI3K, mTOR and p-mTOR and decreased the number of dark neurons.</description><subject>1-Phosphatidylinositol 3-kinase</subject><subject>AKT protein</subject><subject>Animal behavior</subject><subject>Animals</subject><subject>Brain Ischemia - complications</subject><subject>Brain Ischemia - metabolism</subject><subject>Hippocampus</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - metabolism</subject><subject>Immunohistochemistry</subject><subject>Ischemia</subject><subject>Male</subject><subject>Maze Learning - drug effects</subject><subject>Memory</subject><subject>Memory - drug effects</subject><subject>Memory Disorders - drug therapy</subject><subject>Memory Disorders - etiology</subject><subject>Memory Disorders - metabolism</subject><subject>Neurons</subject><subject>Neurons - drug effects</subject><subject>Neurons - metabolism</subject><subject>Neuroprotection</subject><subject>Neuroprotective Agents - pharmacology</subject><subject>Neuroprotective Agents - therapeutic use</subject><subject>Phosphatidylinositol 3-Kinases - metabolism</subject><subject>PI3K/AKT/mTOR signaling</subject><subject>Proto-Oncogene Proteins c-akt - metabolism</subject><subject>Rat</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Reperfusion</subject><subject>Rodents</subject><subject>Selegiline</subject><subject>Selegiline - pharmacology</subject><subject>Selegiline - therapeutic use</subject><subject>Signal transduction</subject><subject>Signal Transduction - drug effects</subject><subject>Spatial memory</subject><subject>TOR protein</subject><subject>TOR Serine-Threonine Kinases - metabolism</subject><issn>0143-4179</issn><issn>1532-2785</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1DAUhS0EotPCC7BAlti0i8z4L3EisakqfqpWaoWGteVxbmY8cuxgJ1PNI_GWOExhwYKVLes7516fg9A7SpaU0Gq1X_oBhiUjtJkfGsFeoAUtOSuYrMuXaEGo4IWgsjlD5yntCSGC1fVrdMYpk6yqxQL9fAwp2Y0DbP0huAP04EccOvx4y-9W13frVb9--IaT3XrtrN_iQY-7J33MOB53gIcYRjCjPQCGrsu3WZvAwdZmHPBlC0MEf3RXWG-19WnEPfQhZoN-0Db-HtcF58LT7G6T2UFvNY4wQOymZIOfR0U9vkGvOu0SvH0-L9D3z5_WN1-L-4cvtzfX94URJRkLw0WrWcs6TaSQRJRtyw0QXdfMaN5ABZuyElAJ2pmGg5Y1YbxpiTC0lBuh-QW6PPnmr_2YII2qz1uBc9pDmJJiLCdcl42UGf3wD7oPU8xBZYoTLmlNm5liJ8rEnHWETg3R9joeFSVqLlLt1VykmotUpyKz6P2z9bTpof0r-dNcBj6eAMhZHCxElYwFb6C1Mdeg2mD_5_8LwTqxiw</recordid><startdate>201910</startdate><enddate>201910</enddate><creator>Amini-Khoei, Hossein</creator><creator>Saghaei, Elham</creator><creator>Mobini, Gholam-Reza</creator><creator>Sabzevary-Ghahfarokhi, Milad</creator><creator>Ahmadi, Reza</creator><creator>Bagheri, Nader</creator><creator>Mokhtari, Tahmineh</creator><general>Elsevier Ltd</general><general>Elsevier Science Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201910</creationdate><title>Possible involvement of PI3K/AKT/mTOR signaling pathway in the protective effect of selegiline (deprenyl) against memory impairment following ischemia reperfusion in rat</title><author>Amini-Khoei, Hossein ; Saghaei, Elham ; Mobini, Gholam-Reza ; Sabzevary-Ghahfarokhi, Milad ; Ahmadi, Reza ; Bagheri, Nader ; Mokhtari, Tahmineh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-c34da2d2fa0747045dd3ce0a882ca39e6eb564e641fc93ea780239d04c157b4a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>1-Phosphatidylinositol 3-kinase</topic><topic>AKT protein</topic><topic>Animal behavior</topic><topic>Animals</topic><topic>Brain Ischemia - complications</topic><topic>Brain Ischemia - metabolism</topic><topic>Hippocampus</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - metabolism</topic><topic>Immunohistochemistry</topic><topic>Ischemia</topic><topic>Male</topic><topic>Maze Learning - drug effects</topic><topic>Memory</topic><topic>Memory - drug effects</topic><topic>Memory Disorders - drug therapy</topic><topic>Memory Disorders - etiology</topic><topic>Memory Disorders - metabolism</topic><topic>Neurons</topic><topic>Neurons - drug effects</topic><topic>Neurons - metabolism</topic><topic>Neuroprotection</topic><topic>Neuroprotective Agents - pharmacology</topic><topic>Neuroprotective Agents - therapeutic use</topic><topic>Phosphatidylinositol 3-Kinases - metabolism</topic><topic>PI3K/AKT/mTOR signaling</topic><topic>Proto-Oncogene Proteins c-akt - metabolism</topic><topic>Rat</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Reperfusion</topic><topic>Rodents</topic><topic>Selegiline</topic><topic>Selegiline - pharmacology</topic><topic>Selegiline - therapeutic use</topic><topic>Signal transduction</topic><topic>Signal Transduction - drug effects</topic><topic>Spatial memory</topic><topic>TOR protein</topic><topic>TOR Serine-Threonine Kinases - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Amini-Khoei, Hossein</creatorcontrib><creatorcontrib>Saghaei, Elham</creatorcontrib><creatorcontrib>Mobini, Gholam-Reza</creatorcontrib><creatorcontrib>Sabzevary-Ghahfarokhi, Milad</creatorcontrib><creatorcontrib>Ahmadi, Reza</creatorcontrib><creatorcontrib>Bagheri, Nader</creatorcontrib><creatorcontrib>Mokhtari, Tahmineh</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neuropeptides (Edinburgh)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Amini-Khoei, Hossein</au><au>Saghaei, Elham</au><au>Mobini, Gholam-Reza</au><au>Sabzevary-Ghahfarokhi, Milad</au><au>Ahmadi, Reza</au><au>Bagheri, Nader</au><au>Mokhtari, Tahmineh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Possible involvement of PI3K/AKT/mTOR signaling pathway in the protective effect of selegiline (deprenyl) against memory impairment following ischemia reperfusion in rat</atitle><jtitle>Neuropeptides (Edinburgh)</jtitle><addtitle>Neuropeptides</addtitle><date>2019-10</date><risdate>2019</risdate><volume>77</volume><spage>101942</spage><epage>101942</epage><pages>101942-101942</pages><artnum>101942</artnum><issn>0143-4179</issn><eissn>1532-2785</eissn><abstract>Short-term cerebral ischemia led to memory dysfunction. There is a pressing need to introduce effective agents to reduce complications of the ischemia. Involvement of PI3K/AKT/mTOR signaling pathway has been determined in the neuroprotective effect of various agents. Selegiline (deprenyl) possessed neuroprotective properties. In this study global ischemia/reperfusion was established in rats. Selegiline (5 mg/kg for 7 consecutive days) administrated via intraperitoneal route. Possible involvement of PI3K/AKT/mTOR signaling pathway was evaluated using qRT-PCR, immunohistochemistry and histophatologic evaluations in the hippocampus. Spatial memory was evaluated by morris water maze (MWM). Results showed that ischemia impaired the memory and ischemic rats spent more time to find hidden platform in the MWM. Ischemia significantly decreased levels of PI3K, AKT and mTOR in the hippocampus. Histopathologic assessment revealed that the percent of dark neurons significantly increased in the CA1 area of the hippocampus of ischemic rats. Selegiline improved the memory as ischemic rats spent fewer time to find hidden platform in the MWM. Findings showed that selegiline increased the level and expression of PI3K, AKT and mTOR as well as decreased the proportion of dark neurons in the CA1 area of the pyramidal layer of the hippocampus. We concluded that selegiline, partially at least, through increases the expression of PI3K, AKT and mTOR as well as decreases the percent of dark neurons in the hippocampus could improve the memory impairment following the ischemia in rats. •Ischemia led to memory dysfunction in rats.•Ischemia reduced the level of AKT, PI3K, mTOR and p-mTOR.•Ischemia increased the percent of dark (dead) neurons in the hippocampus.•Selegiline reversed the negative effect of ischemia on the memory function.•Selegiline increased the level of AKT, PI3K, mTOR and p-mTOR and decreased the number of dark neurons.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>31272684</pmid><doi>10.1016/j.npep.2019.101942</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0143-4179
ispartof Neuropeptides (Edinburgh), 2019-10, Vol.77, p.101942-101942, Article 101942
issn 0143-4179
1532-2785
language eng
recordid cdi_proquest_miscellaneous_2253285977
source ScienceDirect Freedom Collection 2022-2024
subjects 1-Phosphatidylinositol 3-kinase
AKT protein
Animal behavior
Animals
Brain Ischemia - complications
Brain Ischemia - metabolism
Hippocampus
Hippocampus - drug effects
Hippocampus - metabolism
Immunohistochemistry
Ischemia
Male
Maze Learning - drug effects
Memory
Memory - drug effects
Memory Disorders - drug therapy
Memory Disorders - etiology
Memory Disorders - metabolism
Neurons
Neurons - drug effects
Neurons - metabolism
Neuroprotection
Neuroprotective Agents - pharmacology
Neuroprotective Agents - therapeutic use
Phosphatidylinositol 3-Kinases - metabolism
PI3K/AKT/mTOR signaling
Proto-Oncogene Proteins c-akt - metabolism
Rat
Rats
Rats, Sprague-Dawley
Reperfusion
Rodents
Selegiline
Selegiline - pharmacology
Selegiline - therapeutic use
Signal transduction
Signal Transduction - drug effects
Spatial memory
TOR protein
TOR Serine-Threonine Kinases - metabolism
title Possible involvement of PI3K/AKT/mTOR signaling pathway in the protective effect of selegiline (deprenyl) against memory impairment following ischemia reperfusion in rat
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T05%3A33%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Possible%20involvement%20of%20PI3K/AKT/mTOR%20signaling%20pathway%20in%20the%20protective%20effect%20of%20selegiline%20(deprenyl)%20against%20memory%20impairment%20following%20ischemia%20reperfusion%20in%20rat&rft.jtitle=Neuropeptides%20(Edinburgh)&rft.au=Amini-Khoei,%20Hossein&rft.date=2019-10&rft.volume=77&rft.spage=101942&rft.epage=101942&rft.pages=101942-101942&rft.artnum=101942&rft.issn=0143-4179&rft.eissn=1532-2785&rft_id=info:doi/10.1016/j.npep.2019.101942&rft_dat=%3Cproquest_cross%3E2303718197%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c450t-c34da2d2fa0747045dd3ce0a882ca39e6eb564e641fc93ea780239d04c157b4a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2303718197&rft_id=info:pmid/31272684&rfr_iscdi=true